Zhejiang Buduojian is a modern high-tech enterprise integrating R&D, production, sales and service. Located in the beautiful West Lake of Hangzhou, the company takes human health as its own responsibility, integrates the mobile Internet, vigorously develops the research and application of Chinese medicine in the field of chronic disease prevention and rehabilitation, and explores and promotes the management of human health with practical Chinese medicine technology. Always adhere to the corporate purpose of "promoting Chinese medicine culture and benefiting human health" and the corporate mission of "helping more people stay away from diseases and drugs". With the original natural medicine combination therapy, through sunshine, air, drinking water and walking, we can break the traditional concept of taking medicine to support medicine, stay away from the side effects of medicine and break through the traditional medical barriers. Send health gospel to nearly 500 million families and 654.38+04 billion people in China. It belongs to the leading enterprise in the new revolution of medical system! The main product, Buduojian Health Board, has won more than one national patent 100. The first three generations of products have been clinically verified in three phases, and countless users have personally verified it. 20 16 The special documentary "Bu Duo Jian-Human Health Begins with the First Step" was broadcast in the column "Focus Pioneer List" of CCTV Discovery Channel.

20 17 became the designated Buduojian product and gold-level partner of 20 16-20 17 China Volleyball League. At the same time, 20 17 signed a contract with Karolinska Medical College in Sweden to set up a clinical research group on hypertension and stroke, and entered the clinical and mechanism research cooperation between hypertension and cerebral infarction. At the same time, in 20 17, the Ordos municipal government and Bu Duojian cooperated to launch the "Bu Duojian Chronic Disease Prevention and Control and Chinese Medicine Non-intervention Clinical Trial Project", which is progressing very smoothly at present. Among the verified diabetic patients, the improvement rate has gradually increased, and proud achievements have been made in caring for juvenile myopia, helping more children to stay away from myopia, and clinical verification is underway.